Eris Lifesciences Ltd. (ERIS) Lifesciences Share Price trades near 52-week low as stock slips 0.85%

Eris Lifesciences Share Price is in focus today after ERIS traded at Rs 1,142.35, down Rs 9.75 or 0.85%, and stayed close to its 52-week low. The company’s market capitalisation stood at Rs 15,941.06 crore, keeping the move relevant for investors tracking Eris Lifesciences Share Price Today and broader Eris Lifesciences Stock News. The latest Univest data confirms the price event but does not establish a company-specific catalyst. What it does show is that selling pressure has kept the stock near its yearly low while the broader setup remains tied to valuation, sector positioning and recent price action. For readers scanning Eris Lifesciences Share Price Live updates, the current move is modest in percentage terms but meaningful because the stock remains below key moving averages and near support zones watched by the market.

Eris Lifesciences Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,142.35
Previous Close	Rs 1,152.1
Today's Move	Rs -9.75 (-0.85%)
Open	Rs 1,143
High	Rs 1,148.35
Low	Rs 1,141
Market Capitalisation	Rs 15,941.06 crore

Eris Lifesciences Ltd. (ERIS) traded at Rs 1,142.35 versus the previous close of Rs 1,152.1, a fall of 0.85%. The stock opened at Rs 1,143, reached a high of Rs 1,148.35, touched a low of Rs 1,141.

Eris Lifesciences Share Price Today shows a narrow intraday range and a soft opening tone. ERIS opened at Rs 1,143, touched a high of Rs 1,148.35 and a low of Rs 1,141, while last traded at Rs 1,142.35 versus the previous close of Rs 1,152.10. The day’s change of Rs -9.75 or -0.85% places the stock close to its 52-week low and keeps Eris Lifesciences Share Price in the conversation among Stocks in News and Top Losers Today screens. With the market capitalisation at Rs 15,941.06 crore, the share price behaviour suggests cautious sentiment rather than an abrupt repricing. Since the latest Univest data confirms the near yearly low event but does not establish a company-specific catalyst, investors are left to read the move through price action, support and valuation. That makes the next layer of analysis important for Eris Lifesciences Stock Analysis and Eris Lifesciences Share Price Update.

Eris Lifesciences Ltd. (ERIS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 15,941.06 crore
P/E Ratio	24.82x
P/B Ratio	3.96x
ROE	19.23%
ROCE	14.47%
EPS	Rs 46.41
Book Value Per Share	Rs 290.65
Dividend Yield	0%

Eris Lifesciences Ltd. (ERIS) fundamental metrics show P/E 24.82x, P/B 3.96x, ROE 19.23%, ROCE 14.47%. These figures provide context only and are not a buy or sell signal.

Eris Lifesciences Ltd. has a market capitalisation of Rs 15,941.06 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.82x, P/B at 3.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.23% and ROCE of 14.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 46.41, book value per share of Rs 290.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.47x, median ROE of 11.32%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	24.82x
Benchmark Median P/E	27.47x
Benchmark Average P/E	39.69x
Benchmark P/E Range	0x to 640x
Company P/B Ratio	3.96x
Benchmark Median P/B	2.81x
Company ROE	19.23%
Benchmark Median ROE	11.32%
Company ROCE	14.47%
Benchmark Median ROCE	13.17%
Company Market Capitalisation	Rs 15,941.06 crore
Benchmark Median Market Cap	Rs 795.25 crore

Eris Lifesciences Ltd. (ERIS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 24.82x, which is below the benchmark median of 27.47x, a difference of -9.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Eris Lifesciences Ltd. (ERIS) has a ROE of 19.23%, which is above the benchmark median of 11.32%, a difference of +69.88%. Eris Lifesciences Ltd. (ERIS) has a ROCE of 14.47%, which is above the benchmark median of 13.17%, a difference of +9.87%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Alembic Pharmaceuticals Ltd.	APLLTD	15,573.7	22.44	2.66	12.35	11.74
Glenmark Life Sciences Ltd.	ALIVUS	16,490.05	27.35	4.73	18.41	24.61
Natco Pharma Ltd.	NATCOPHARM	15,359.95	13.45	1.65	16.3	17.16
ONESOURCE SPECL PHARMA L	ONESOURCE	16,562.91	0	2.81	-1.26	0.44
Jubilant Pharmova Ltd.	JUBLPHARMA	14,955.7	42.44	2.1	5.97	8.69

Eris Lifesciences Ltd. (ERIS) has a P/E ratio of 24.82x compared with the displayed peer median of 22.44x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.23% compares with a peer median of 12.35% across the companies shown in the table. ROCE stood at 14.47% versus the displayed peer median of 11.74%, providing a capital-efficiency comparison. Eris Lifesciences Ltd. (ERIS) has a market capitalisation of Rs 15,941.06 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Eris Lifesciences

• Eris Lifesciences Share Price is trading close to a 52-week low, so price action is now a key focus.
• The stock is below the 50 DMA of Rs 1,249.93 and the 200 DMA of Rs 1,339.65, which keeps the broader trend soft.
• ROE of 19.23% and ROCE of 14.47% show that the business is still generating solid returns.
• Sector benchmarking shows ERIS below the industry median P/E but above the median P/B, which keeps valuation in view.
• The healthcare and pharmaceuticals backdrop makes Eris Lifesciences Latest News relevant for investors tracking sector rotation and stock-specific price action.

About Eris Lifesciences

About Eris Lifesciences, the company operates in pharmaceuticals and drugs within the Healthcare sector. Eris Lifesciences is known for building a specialty-focused pharma franchise in India, and its financial profile suggests a business that has scaled enough to sit among larger listed healthcare names. The latest revenue figure available in this update is Rs 873.25 crore for Jun 2026, which provides a useful anchor for understanding operating scale. For readers following Eris Lifesciences Company News, the key point is that the business is being assessed by the market through earnings quality, return ratios and valuation rather than through a narrow price-only lens. That is why Eris Lifesciences Share Price remains relevant even when the market does not assign a fresh catalyst. It is the intersection of business model, profitability and price behaviour that keeps the stock in focus.

Track Eris Lifesciences Share Price on Univest

Use Eris Lifesciences Ltd. (ERIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

You can track Eris Lifesciences Share Price on Univest for live price movement, technical indicators, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers compare Eris Lifesciences Share Price Today with sector context, peer valuation and broader Indian Stock Market trends in a simple format.

Frequently Asked Questions

Why is Eris Lifesciences Share Price falling today?

Ans. Eris Lifesciences Share Price was down 0.85% at Rs 1,142.35. The latest Univest data confirms the near 52-week low event, but it does not establish a company-specific catalyst for the move.

What is Eris Lifesciences Share Price Today?

Ans. Eris Lifesciences Share Price Today was Rs 1,142.35, compared with the previous close of Rs 1,152.10. The stock moved between Rs 1,141 and Rs 1,148.35 during the latest reading. The stock moved -0.85% during the session.

Is Eris Lifesciences trading near its 52-week low?

Ans. Yes. Eris Lifesciences Share Price is near its 52-week low and yearly low zone, which is why it is drawing attention in Stocks in News and Top Losers Today screens.

What does the valuation of Eris Lifesciences Share Price show?

Ans. Eris Lifesciences trades at a P/E of 24.82 and P/B of 3.96. That places the stock below the industry median P/E, while P/B remains above the industry median. The stock moved -0.85% during the session.

How strong are the fundamentals behind Eris Lifesciences Share Price?

Ans. Eris Lifesciences reports ROE of 19.23%, ROCE of 14.47%, EPS of Rs 46.41 and book value of Rs 290.65. These figures support a stable fundamental profile. The stock moved -0.85% during the session.

How does Eris Lifesciences compare with healthcare peers?

Ans. Compared with listed pharma peers, Eris Lifesciences has a mid-range valuation and stronger returns than several names in the sector. Its market capitalisation of Rs 15,941.06 crore also places it among larger healthcare stocks.

What should investors monitor in Eris Lifesciences Share Price next?

Ans. Investors should monitor whether Eris Lifesciences stays near support, how it trades versus the 50 DMA of Rs 1,249.93 and 200 DMA of Rs 1,339.65, and whether sector-relative valuation stays stable.